Home / Industry / Blog / Alma UK Offers Support to Clinics and Laser Aid Team Affected by Recent Closure
02 May 2025

Alma UK Offers Support to Clinics and Laser Aid Team Affected by Recent Closure

Alma UK Offers Support to Clinics and Laser Aid Team Affected by Recent Closure

Following the recent closure of Laser Aid, Alma UK has expressed its support for the clinics and professionals affected by the disruption. Acknowledging the challenges this presents, Alma UK is offering both immediate and ongoing support to help ensure continuity for those impacted.

As a provider of advanced aesthetic technologies, Alma UK is offering practical, cost-effective solutions to clinics and practitioners. In response to the gap left by Laser Aid, the company is aiming to assist with service continuity and equipment needs.

Support for Clinics
Clinics affected by the closure are being offered service support, continuation of service contracts, and access to discounted Alma UK devices. Alma UK equipment is used by professionals in the UK and internationally, and the company is making these technologies available to help clinics maintain their operations.

Support for Former Laser Aid Staff
Alma UK is also providing support for former Laser Aid staff. This includes access to training and assistance with career development. The company is open to discussions with individuals seeking new roles, whether within Alma UK or in other parts of the sector.

Alma UK's response is intended to help affected clinics and professionals manage the impact of Laser Aid’s closure and continue delivering services to their clients.

“We understand the impact of this closure, and our priority is to offer practical solutions to help both clinics and professionals continue to thrive,” said Kamran Shibli, General Manager of Alma UK. “Our team is ready to step in with both the technology and the human support needed to ensure that the transition is as seamless as possible.”
Kamran Shibli · 02-05-2025

Read it? Loved it? Want to share it?

Share On Instagram Share On Twitter Share On Facebook Share On LinkedIn